Results 251 to 260 of about 14,337,199 (401)

Percutaneous endocardial alginate–hydrogel injection in the treatment of heart failure: First‐in‐human study

ESC Heart Failure, EarlyView.
Using EndoWings™ and XDROP™, we developed a percutaneous minimally invasive technique for sequential circumferential alginate hydrogel injection into LV free mid‐wall. This human study assessed its safety/feasibility in HFrEF patients, with personalised biomechanical models.
Bo Wang, Shuo Wang, Chao Gao, D. Scott Lim, Rutao Wang, Xin Meng, Ying Liu, Cun‐jun Zhu, Yoshinobu Onuma, Yunbing Wang, Patrick W.J.C. Serruys, Runlin Gao, Randall J. Lee, Ling Tao   +13 more
wiley   +1 more source

Cardiac Troponin I Biosensors: Innovations in Real-Time Diagnosis of Cardiovascular Diseases. [PDF]

Anal Sci Adv
Ebrahimi S, Alivirdiloo V, Hajiabbasi M, Masoumi S, Mohammadi M, Hosseini S, Gargari SO, Mobed A.   +7 more
europepmc   +1 more source

Does a decrease in troponin I phosphorylation explain the altered functional properties of troponin in failing heart muscle? [PDF]

, 2000
Steven B. Marston, Ian Purcell, A Knott
openalex   +1 more source

Worsening versus advanced heart failure: Management and challenges

ESC Heart Failure, EarlyView.
Clinical feature, circulating biomarkers and therapeutic management of patients with WHF versus AdvHF. Abbreviations: AdvHF, advanced heart failure; HF, heart failure; HTx, heart transplant; GDMT, guideline‐directed medical therapy; MCS, mechanical circulatory support; NYHA, New York Heart Association; WHF, worsening heart failure.
Alberto Palazzuoli, Marco Giuseppe Del Buono, Giulia La Vecchia, Stephen J. Greene, Andrew P. Ambrosy, Ovidiu Chioncel, Finn Gustafsson, Selim R. Krim, Carl J. Lavie, Marianna Adamo, Tuvia Ben Gal, Oliviana Geavlete, Laura Antohi, Giuseppe Rosano, Sean Collins, Filippo Crea   +15 more
wiley   +1 more source

Diagnostic performance and risk assessment of combined copeptin and high-sensitivity cardiac troponin I in Chinese emergency department. [PDF]

Int J Cardiol Heart Vasc
Sun J, Chen X, Huang Y, Tang Y, Du Y, Gu X, Liao J.   +6 more
europepmc   +1 more source

Discordance with 3 Cardiac Troponin I and T Assays: Implications for the 99th Percentile Cutoff.

Clinical Chemistry, 2016
J. Ungerer, J. Tate, C. Pretorius
semanticscholar   +1 more source

Long‐term prognosis of pure and impure tachycardiomyopathy

ESC Heart Failure, EarlyView.
Abstract Background and aims Tachycardia‐induced cardiomyopathy (TCM) is a reversible form of heart failure (HF) driven by arrhythmias, often atrial fibrillation (AF). While reversible, TCM's long‐term prognosis remains unclear, especially in comparison to HF with reduced ejection fraction (HFrEF).
Giulia Stronati, Michele Alfieri, Niki Tombolesi, Alessandro Barbarossa, Samuele Principi, Federico Gullì, Arianna Massari, Gianmarco Bastianoni, Francesca Roccetti, Michela Casella, Antonio Dello Russo, Federico Guerra   +11 more
wiley   +1 more source

Triple-Function-Intensified Photoelectric Immunosensing Platform for One-Step Detection of Cardiac Troponin I. [PDF]

ACS Appl Mater Interfaces
Yeh SC, Chen WS, Ko WY, Lin KJ.
europepmc   +1 more source

A Prospective Study of an Algorithm Using Cardiac Troponin I and Myoglobin as Adjuncts in the Diagnosis of Acute Myocardial Infarction and Intermediate Coronary Syndromes in a Veteran's Hospital [PDF]

, 2000
Alan S. Maisel, Kathleen Templin, MBChB MRCP Michael P. Love, Paul Clopton   +3 more
openalex   +1 more source

Impact of High-Sensitivity Troponin I Testing with Sex-Specific Cutoffs on the Diagnosis of Acute Myocardial Infarction.

Clinical Chemistry, 2016
Christina M. Trambas, J. Pickering, M. Than, Chris Bain, Lucy Nie, E. Paul, A. Dart, Arch Broughton, H. Schneider   +8 more
semanticscholar   +1 more source